PRJNA207719: Tissue specific transcriptome profiling
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
en1a | dr11_v1_chr9_-_785444_785444 | -0.51 | 3.8e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr10_+_28428222 Show fit | 1.01 |
ENSDART00000135003
|
si:ch211-222e20.4 |
|
chr5_-_44843738 Show fit | 0.96 |
ENSDART00000003926
|
fructose-1,6-bisphosphatase 1a |
|
chr16_+_26017360 Show fit | 0.95 |
ENSDART00000149466
|
protease, serine, 59, tandem duplicate 2 |
|
chr19_-_18626515 Show fit | 0.91 |
ENSDART00000160624
|
ribosomal protein S18 |
|
chr3_+_14543953 Show fit | 0.88 |
ENSDART00000161710
|
erythropoietin receptor |
|
chr3_-_3939785 Show fit | 0.86 |
ENSDART00000049593
|
un-named sa1506 |
|
chr2_-_51794472 Show fit | 0.84 |
ENSDART00000186652
|
|
|
chr20_-_25518488 Show fit | 0.84 |
ENSDART00000186993
|
cytochrome P450, family 2, subfamily N, polypeptide 13 |
|
chr7_-_20582842 Show fit | 0.80 |
ENSDART00000169750
ENSDART00000111719 |
si:dkey-19b23.11 |
|
chr18_-_43866526 Show fit | 0.74 |
ENSDART00000111309
|
trehalase (brush-border membrane glycoprotein) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.8 | GO:0042737 | drug metabolic process(GO:0017144) drug catabolic process(GO:0042737) exogenous drug catabolic process(GO:0042738) |
0.1 | 1.2 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.3 | 1.0 | GO:0005986 | sucrose metabolic process(GO:0005985) sucrose biosynthetic process(GO:0005986) disaccharide biosynthetic process(GO:0046351) |
0.2 | 0.9 | GO:0003210 | cardiac atrium formation(GO:0003210) |
0.1 | 0.8 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.2 | 0.7 | GO:0005991 | disaccharide metabolic process(GO:0005984) trehalose metabolic process(GO:0005991) |
0.1 | 0.7 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.1 | 0.7 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.1 | 0.6 | GO:0001781 | neutrophil apoptotic process(GO:0001781) regulation of T-helper 1 type immune response(GO:0002825) positive regulation of T-helper 1 type immune response(GO:0002827) negative regulation of type 2 immune response(GO:0002829) inflammatory cell apoptotic process(GO:0006925) regulation of prostaglandin biosynthetic process(GO:0031392) positive regulation of prostaglandin biosynthetic process(GO:0031394) regulation of phospholipase A2 activity(GO:0032429) interleukin-2 production(GO:0032623) regulation of interleukin-2 production(GO:0032663) positive regulation of interleukin-2 production(GO:0032743) myeloid cell apoptotic process(GO:0033028) regulation of neutrophil apoptotic process(GO:0033029) positive regulation of neutrophil apoptotic process(GO:0033031) regulation of myeloid cell apoptotic process(GO:0033032) positive regulation of myeloid cell apoptotic process(GO:0033034) T-helper 1 type immune response(GO:0042088) positive regulation of CD4-positive, alpha-beta T cell differentiation(GO:0043372) T-helper 1 cell differentiation(GO:0045063) positive regulation of T-helper cell differentiation(GO:0045624) regulation of T-helper 1 cell differentiation(GO:0045625) positive regulation of T-helper 1 cell differentiation(GO:0045627) regulation of T-helper 2 cell differentiation(GO:0045628) negative regulation of T-helper 2 cell differentiation(GO:0045629) positive regulation of fatty acid biosynthetic process(GO:0045723) positive regulation of alpha-beta T cell differentiation(GO:0046638) neutrophil clearance(GO:0097350) negative regulation of phospholipase A2 activity(GO:1900138) positive regulation of CD4-positive, alpha-beta T cell activation(GO:2000516) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.0 | 0.6 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 2.2 | GO:0015935 | small ribosomal subunit(GO:0015935) |
0.1 | 0.7 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.0 | 0.7 | GO:0016342 | catenin complex(GO:0016342) |
0.0 | 0.6 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 0.6 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 0.5 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.0 | 0.5 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.1 | 0.4 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.0 | 0.3 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.0 | 0.3 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 3.8 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 1.9 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 1.8 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.1 | 1.2 | GO:0016405 | CoA-ligase activity(GO:0016405) |
0.3 | 1.0 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
0.0 | 0.9 | GO:0019843 | rRNA binding(GO:0019843) |
0.2 | 0.8 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.1 | 0.8 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.2 | 0.7 | GO:0015927 | alpha,alpha-trehalase activity(GO:0004555) trehalase activity(GO:0015927) |
0.1 | 0.7 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.4 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 0.9 | PID EPO PATHWAY | EPO signaling pathway |
0.0 | 0.5 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.3 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.2 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.8 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.0 | 0.8 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 0.7 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.7 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 0.6 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.0 | 0.6 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.4 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 0.4 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 0.3 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 0.3 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |